EUVIMEDEUVIMED entdecken
Crossref

An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes. Preliminary experience with telemedicine in 6 patients

Raffaella Fresa, Olimpia Bitterman, Vincenzo Cavallaro, Marianna Di Filippi, Daniela Dimarzo, Carmela Mosca, Francesca Nappi, Marilena Rispoli, Angela Napoli

Acta Diabetologica · 2024

DOI: 10.1007/s00592-024-02315-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Diabetologica, 2024. Verfasst von Raffaella Fresa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Diabetology Outpatient Clinic , Asl Salerno, District 63, Salerno, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Telemedicine, Insulin Infusion Systems, Insulin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The use of most commercially available automated insulin delivery (AID) systems is off-label in pregnancy. However, an increasing number of women with type 1 diabetes (T1D) use such devices throughout pregnancy and delivery. We analysed the data of six women with T1D from a single centre (Diabetology Outpatient Clinic of District-63/Asl Salerno, Italy) who were able to start and maintain AID therapy with the MiniMed™ 780G (Medtronic, Minneapolis, MN, USA) throughout the pregestational care period, pregnancy, delivery, and postpartum. METHODS: We retrospectively collected data from six patients with T1D who received training and initiation on use of the MiniMed™ 780G and attended follow-up visits throughout pregnancy (these visits were virtual because of the COVID-19 pandemic). All patients maintained their devices in the closed-loop setting throughout pregnancy and during labour and delivery. We analysed data from the pregestational phase to the first 30 days postpartum. RESULTS: All patients achieved the recommended metabolic goals before conception [median time in range (TIR) of 88% for 70-180 mg/dL; median pregnancy-specific TIR 63-140 mg/dL (ps-TIR) of 66% and maintained the ps-TIR until delivery (median ps-TIR 83%). All patients had slightly better metrics during the night than during the day, with a very low time below range of < 63 mg/dL. Optimal glycaemic values were also maintained on the day of labour and delivery (median ps-TIR 92.5%) and in the first 30 days postpartum, with no severe hypoglycaemia. The only neonatal complications were jaundice in one child and an interatrial defect in another child. CONCLUSION: In our well-selected and trained patients, use of the MiniMed™ 780G helped to achieve and maintain ps-metrics from the pregestational period to delivery despite the fact that the algorithm is not set to achieve the ambitious glycaemic values recommended for pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1TelemedicineInsulin Infusion SystemsInsulinPregnancy in DiabeticsPostpartum PeriodHumansFemalePregnancyAdultRetrospective StudiesHypoglycemic AgentsBlood GlucoseCOVID-19Italy

Stichwörter der Autor:innen

Insulin pumpPregnancyTelemedicineType 1 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Diabetology Outpatient Clinic , Asl Salerno, District 63, Salerno, Italy.
  • Diabetology Unit, San Paolo Hospital, ASL Roma 4, Civitavecchia, Rome, Italy. olimpia.bitterman@gmail.com.
  • Israelitico Hospital, Rome, Italy.
  • International Medical University Unicamillus, Rome, Italy.
  • Cdc Santa Famiglia, Rome, Italy.

Zitieren

APA

Fresa, R., Bitterman, O., Cavallaro, V., Di Filippi, M., Dimarzo, D., Mosca, C., Nappi, F., Rispoli, M., & Napoli, A. (2024). An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes. Preliminary experience with telemedicine in 6 patients. Acta Diabetologica. https://doi.org/10.1007/s00592-024-02315-z

Vancouver

Fresa R, Bitterman O, Cavallaro V, Di Filippi M, Dimarzo D, Mosca C, et al. An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes. Preliminary experience with telemedicine in 6 patients. Acta Diabetologica. 2024. doi:10.1007/s00592-024-02315-z

BibTeX
@article{Fresa2024,
  author = {Fresa, Raffaella and Bitterman, Olimpia and Cavallaro, Vincenzo and Di Filippi, Marianna and Dimarzo, Daniela and Mosca, Carmela and Nappi, Francesca and Rispoli, Marilena and Napoli, Angela},
  title = {An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes. Preliminary experience with telemedicine in 6 patients},
  journal = {Acta Diabetologica},
  year = {2024},
  doi = {10.1007/s00592-024-02315-z}
}
Kostenlos starten →